Home/Filings/4/0001619856-23-000020
4//SEC Filing

Rizvi Syed Ali-aamir 4

Accession 0001619856-23-000020

CIK 0001619856other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:09 PM ET

Size

5.5 KB

Accession

0001619856-23-000020

Insider Transaction Report

Form 4
Period: 2023-02-21
Rizvi Syed Ali-aamir
Chief Medical Officer
Transactions
  • Award

    Option to purchase Common Stock

    2023-02-21+131,000131,000 total
    Exercise: $6.12Exp: 2033-02-20Common Stock (131,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.

Issuer

Caribou Biosciences, Inc.

CIK 0001619856

Entity typeother

Related Parties

1
  • filerCIK 0001897621

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:09 PM ET
Size
5.5 KB